Brief: Everest Medicines Says From 20 May To 21 May, CBC Group Buys 600,500 Shares For HK$19.2 Mln
22/05/2026 02:37
May 22 (Reuters) - Everest Medicines Ltd 1952.HK: FROM 20 MAY TO 21 MAY, CBC GROUP PURCHASES 600,500 SHARES FOR HK$19.2 MILLION AT HK$31.91 PER SHARE Further company coverage: 1952.HK ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Everest Medicines
See all newsBrief: Everest Medicines Says NMPA Approves Cardamyst (Etripamil) NDA For PSVT In Adults In China
Brief: Everest Medicines Enters Commercialization Collaboration With Hainan Herui Pharmaceutical
Brief: Everest Medicines Says CBC Group Purchases 712,000 Everest Medicines Shares For Hk$19.2 Million From 16 To 17 June
Australia's Dimerix soars on commercialisation deal with Everest Medicines
Brief: Dimerix Ltd Licenses Dmx200 To Everest For China And Asia Region